Details for New Drug Application (NDA): 218462
✉ Email this page to a colleague
The generic ingredient in TOFACITINIB is tofacitinib citrate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tofacitinib citrate profile page.
Summary for 218462
Tradename: | TOFACITINIB |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | tofacitinib citrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 11MG BASE | ||||
Approval Date: | Jun 3, 2024 | TE: | RLD: | No |
Complete Access Available with Subscription